Tag Archives: HMNY

Best Health Care Stocks For 2019

Stocks finished ever so slightly lower today as the election looms, the Federal Reserve geared up for its November meeting beginning tomorrow, and earning season continued apace.

Getty Images

The S&P 500 declined 0.01% to
2,126.15 today, while the Dow Jones Industrial Average declined 18.77 points, or 0.1%, to 18,142.42. The Nasdaq Composite finished off 0.02% at 5,189.13.

If it was just earnings, we probably wouldn’t be stuck in this rut. Deutsche Bank’s David Bianco and team, for one,  contend that the so-called earnings recession appears to be ending:

Macro conditions were challenging in 3Q, US and globally, especially for capital goods demand and related manufacturing. Commodity prices were weak, non-res construction flat, very slow trade, soft and promotional retailing, stable but paralyzed global markets. Despite this backdrop, 3rd qtr S&P EPS appears likely to rise 2-3% y/y, thus exiting the profit recession and likely the best S&P EPS growth ex. Energy in a year at ~6%. The drivers of this improvement are not cyclical sectors like Industrials or Con Disc, but rather Financials, encouraging acceleration at Tech (ex AAPL) and continued superior high single-digit growth at Health Care. These 3 sectors are 50%+ of S&P EPS.

Best Health Care Stocks For 2019: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    McDermott International, Inc. (NYSE: MDR) rose 19 percent to $7.20 in pre-market trading. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott.
    Clarus Corporation (NASDAQ: CLAR) rose 18.5 percent to $8.00 in pre-market trading.
    Enbridge Inc. (NYSE: ENB) rose 9.3 percent to $34.09 in pre-market trading after falling 2.41 percent on Friday.
    Lannett Company, Inc. (NYSE: LCI) rose 8.4 percent to $18 in pre-market trading. Lannett named Maureen M. Cavanaugh as senior vice president and chief commercial operations officer.
    Navios Maritime Midstream Partners L.P. (NYSE: NAP) rose 7.1 percent to $4.55 in pre-market trading after gaining 11.26 percent on Friday.
    Corcept Therapeutics Incorporated (NASDAQ: CORT) rose 6.9 percent to $18.80 in pre-market trading after falling 3.19 percent on Friday.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 5.7 percent to $2.40 in pre-market trading after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.6 percent to $69.20 in pre-market trading. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash
    Genprex, Inc. (NASDAQ: GNPX) shares rose 5.2 percent to $4.50 in pre-market trading.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 5.1 percent to $3.70 in pre-market trading after declining 19.35 percent on Friday.
    Sangamo Therapeutics, Inc. (NASDAQ: SGMO) shares rose 5 percent to $20 in pre-market trading.
    Magellan Midstream Partners, L.P. (NYSE: MMP) shares rose 5 percent to $68.41 in pre-market trading.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares rose 4.9 percent to $19.78 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Rich Smith]

    For the past several weeks, MoviePass owner Helios and Matheson Analytics (NASDAQ:HMNY) has issued press releases describing the health of its business — mostly in terms other than dollars and cents. Some of the news has been good. Some of the news…hasn’t.

  • [By Paul Ausick]

    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) traded down about 9.7% Monday to post a new 52-week low of $0.28 after closing Friday at $0.31. The stock’s 52-week high is $38.86. Volume was about 10% below the daily average of around 17.6 million shares. The owner of MoviePass continues on a path to self-immolation.

Best Health Care Stocks For 2019: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PDC Energy Inc (NASDAQ:PDCE) EVP Lance Lauck sold 1,000 shares of the firm’s stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $49.09, for a total transaction of $49,090.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Matthew DiLallo]

    Shares of PDC Energy Inc. (NASDAQ:PDCE) lost 15.2% of their value in August, due in part to the oil and gas company’s disappointing second-quarter report.

  • [By Matthew DiLallo]

    In addition to supporting the growth of its parent, Noble Midstream will also assist third-party producers. One of the drivers is a partnership it formed with a private-equity-backed midstream company last year to buy the Black Diamond Gathering system in the DJ Basin. That system initially supported the production of six customers, including PDC Energy (NASDAQ:PDCE). However, the partners have gone on to expand their relationship with PDC Energy as well as recently adding a new customer into the fold, which has enhanced the system’s growth prospects.

  • [By Ethan Ryder]

    PDC Energy (NASDAQ:PDCE) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

Best Health Care Stocks For 2019: Flowserve Corporation(FLS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Press coverage about Flowserve (NYSE:FLS) has trended somewhat positive on Saturday, according to Accern. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Flowserve earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned media coverage about the industrial products company an impact score of 46.7836910204953 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion.
    News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion.
    Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion.
    Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion.
    Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million.
    Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million.
    Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million.
    Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million.
    The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million.
    Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million.
    Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million.
    Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million.
    TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million.
    Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million.
    Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million.
    Jagged Peak En

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Flowserve (FLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Seaport Global Securities restated their hold rating on shares of Flowserve (NYSE:FLS) in a report released on Monday morning. They currently have a $47.00 target price on the industrial products company’s stock. Seaport Global Securities also issued estimates for Flowserve’s Q4 2018 earnings at $0.57 EPS, FY2018 earnings at $1.70 EPS, Q2 2019 earnings at $0.53 EPS and FY2019 earnings at $2.08 EPS.

Hot Small Cap Stocks To Buy For 2019

Small cap police body cam stockDigital Ally, Inc (NASDAQ: DGLY) reportedQ3 2017 earnings after the market closed on Tuesday. Media generated police controversies have helpedpolice body cam players like Digital Ally,theclosest thing to a pure play police body cam stock. However, Digital Ally and body cam competitor Axon Enterprise (NASDAQ: AAXN), formerly known as TASER International, Inc (NASDAQ: TASR), have also been embroiled in messy patent infringement lawsuits.

Total revenue decreased 31.2% to approximately $3.0 million with the primary reason for the revenue decrease was the halt of deliveries under the AMR contract, which was expected to generate significant revenues in the third quarter. In the third quarter 2016, the Company generated revenues in excess of $760,000 on one contract with a large international customer that did not recur in 2017. Additionally, law enforcement revenues declined over the prior period due to price-cutting and other actions by competitors and adverse marketplace effects related to the patent litigation. The net loss of was $3,493,306 versus a net loss of $3,255,579. The CEO made extensive comments that included:

Hot Small Cap Stocks To Buy For 2019: Regal Entertainment Group(RGC)

Advisors’ Opinion:

  • [By Peter Graham]

    In December, UK based Cineworld Group Plc also agreed tobuy larger U.S. peer Regal Entertainment Group (NYSE: RGC) for $3.6 billion in cash in adeal to create the world’s second largest movie theatre operator after AMC Entertainment Holdings. The combined entity is expected to be better able to compete AMC.

Hot Small Cap Stocks To Buy For 2019: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

  • [By Paul Ausick]

    Helios and Matheson Analytics, Inc. (NASDAQ: HMNY) fell by about 9.8% Friday to post a new 52-week low of $0.55 after closing at $0.66 on Thursday. The 52-week high is $38.86. Volume of about 28 million was more more than three times the daily average of about 7.8 million. The company said in a Monday SEC filing that it needs to raise more cash to prop up its MoviePass business. Investors are not buying the week-long dip here..

  • [By Rick Munarriz]

    Simple math would tell you that this is inferior to Helios and Matheson Analytics’ (NASDAQ:HMNY)MoviePass, a platform that costs half as much and allows as many as seven movies a week — as long as none of them are repeat screenings. MoviePass is also available across most theaters across the country, while AMC Stubs A-List is naturally limited to showings at AMC properties. However, AMC has two things going for it, and MoviePass can’t take its pole position for granted in this race.

  • [By Lisa Levin]

    Shares of Helios and Matheson Analytics Inc. (NASDAQ: HMNY) were down 40 percent to $2.29 after pricing public share offering.

    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) was down, falling around 29 percent to $2.30. Sears Hometown and Outlet Stores reported a Q4 loss of $1.46 per share on revenue of $395.77 million.

Hot Small Cap Stocks To Buy For 2019: First Busey Corporation(BUSE)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of First Busey Co. (NASDAQ:BUSE) hit a new 52-week high and low during trading on Monday . The company traded as low as $33.22 and last traded at $32.70, with a volume of 1006 shares traded. The stock had previously closed at $33.00.

  • [By Max Byerly]

    First Busey Co. (NASDAQ:BUSE) – Equities researchers at B. Riley decreased their Q2 2018 earnings estimates for First Busey in a report released on Tuesday, June 19th. B. Riley analyst S. Moss now expects that the bank will post earnings per share of $0.53 for the quarter, down from their previous forecast of $0.57. B. Riley has a “Buy” rating and a $36.00 price objective on the stock. B. Riley also issued estimates for First Busey’s Q3 2018 earnings at $0.55 EPS, Q4 2018 earnings at $0.59 EPS, FY2018 earnings at $2.18 EPS, Q1 2019 earnings at $0.57 EPS, Q3 2019 earnings at $0.59 EPS, Q4 2019 earnings at $0.63 EPS and FY2019 earnings at $2.38 EPS.

  • [By Stephan Byrd]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of First Busey Co. (NASDAQ:BUSE) during the 1st quarter, Holdings Channel reports. The firm bought 7,000 shares of the bank’s stock, valued at approximately $208,000.

  • [By Ethan Ryder]

    BidaskClub downgraded shares of First Busey (NASDAQ:BUSE) from a buy rating to a hold rating in a research report sent to investors on Saturday morning.

If MoviePass Dies, AMC Is Going to Feel the Pain

We may not get a Hollywood ending for MoviePass parentHelios and Matheson Analytics (NASDAQ:HMNY). The stock tumbled 31% on Tuesday after an SEC filing confirmed the cash crunch facing the seemingly unsustainable business model.

Helios and Matheson had just $15.5 million in available cash at the end of April. There’s another $27.9 million on deposit with merchant processors from the sale of annual and quarterly payment plans that will be available to Helios and Matheson as the year plays out. There doesn’t seem to be a lot of dry powder left for a company that admits it’s losing more than $20 million a month. MoviePass is on the brink of buckling absent a cash infusion or an outright buyout, but multiplex operators that are talking down MoviePass may regret getting what they want if the movie subscription service goes belly up.

AMC 14 in Saratoga.

Image source: AMC Entertainment.

The silver screen goes for the bronze

MoviePass in its current form is built to scale quickly at the expense of burning through a ton of dough in the process. For $9.95 a month, a person can catch a standard movie screening every single day at most local movie theaters. Entertainment smorgasbord subscriptions are exploding in popularity, but it’s typically through digital platforms where costs can be reasonably controlled.

MoviePass is bananas. It has to pay retail prices at most chains, and even AMC Entertainment (NYSE:AMC) is trolling the platform these days. MoviePass came up during AMC’s earnings call earlier this week. AMC CEO Adam Aron points out that “hundreds of thousands” of MoviePass subscribers come to AMC Theatres, doing so at a frequency of 2.62 times in March and 2.75 in April. MoviePass is paying AMC $12.02 per movie, far more than the $9.78 average price per ticket at AMC during the quarter. MoviePass members tend to see more expensive screenings. Why go see a cheaper matinee when it’s on someone else’s dime?

AMC has been openly critical of MoviePass, arguing that it devalues the theatergoing experience. There’s some truth to that opinion, and Aron took a swing at the sustainability of its model during Monday’s earnings call.

“I took a calculator out, and I multiplied 2.75 times 12.02,” Aron said. “I got to a number that was considerably larger than $9.95.”

AMC has been dissing MoviePass since last summer, when Helios and Matheson acquired a controlling stake in the service, slashing its price to $9.95 a month. The problem with movie theater chains trying to work against MoviePass than finding a way to make it work is that if MoviePass goes under, most of those subscribers aren’t coming back. MoviePass may very well go under this year, but so will the hundreds of thousands of members seeing nearly three movies a month at AMC. Those who do stick around will naturally be buying cheaper tickets on average.

Tickets, please

The cash crunch is real. Helios and Matheson stock took a hit in mid-April when it raised $30 million through a dilutive stock offering. Now we learn that MoviePass had just $15.5 million in available cash less than two weeks later.

It’s going to be easy for MoviePass to raise money through another stock offering, and it’s a bad credit risk now that even its auditors have voiced their doubts about the business. MoviePass has been able to improve its cash flow by selling discounted annual passes in the past, but would you pay up front for a service that may not be around during the term of the offer?

A silver lining here is that MoviePass did say that it’s been able toreduce its cash deficit during the first week of May by more than 35% after rolling out initiatives that curb the use and more importantly misuse of its product. MoviePass accounts are now tethered to a single smartphone, preventing the widespread sharing in the past of subscriber accounts with friends and family. MoviePass is also now enforcing its rule that limits the ability to see the same movie twice, a move that curbs usage with some of its more active users.

The model needs mending. MoviePass mentioned in an interview last week that it would be rolling out new plans for families, groups, and even the premium screenings that it doesn’t presently offer. It also has ambitious plans to subsidize some of its losses through advertising, selling user data, sponsorships, and marketing merchandise. It will need time to see any of these incremental revenue streams through, but now time is not on its side.

The same company that was saying that it’s running at a cash-deficit average of $20 million a month through the six months ending in March is now saying it lost an average of $21.7 million through the seven months ending in April. In other words, it lost more than $30 million last month.

MoviePass may go down if it doesn’t find a fat-cat suitor interested in reaching its nearly 3 million members, but if it does go down, it will probably take a few cocky multiplex operators down in the process.

Top Undervalued Stocks To Buy Right Now

Hywind wind farm concept. Five turbines will be placed off the east coast of Scotland, near Peterhead. They will each be anchored with three suction anchors and linked together to send electricity to shore to power 22,000 households. Source: Statoil.

Seeking Alpha contributor Michael Fitzsimmons has summarized Statoil’s (NYSE:STO) Q2 results, which he suggests show that the company is undervalued and operating successfully with oil at $50/bbl or less. With net income of $0.44/share, Q2 dividend of $0.22/share and 8.1% debt ratio reduction, things looks sweet even in these challenging times. However, there is more good news to the Statoil story. Here I have a look at what Statoil is doing about growing a future beyond oil.

Top Undervalued Stocks To Buy Right Now: First Horizon National Corporation(FHN)

Advisors’ Opinion:

  • [By ]

    In an “Executive Decision” segment, Cramer sat down with Bryan Jordan, chairman, president and CEO of First Horizon National (FHN) , the Tennessee-based regional bank that just posted a three-cents-a-share earnings beat with net interest margins up 52 basis points.

  • [By ]

    In his second “Executive Decision” segment, Cramer also sat down with Bryan Jordan, chairman, president and CEO of First Horizon National (FHN) , the Tennessee-based regional bank that just posted a three-cents-a-share earnings beat with net interest margins up 52 basis points.

  • [By ]

    In this environment, investors should be looking to add the banks to their portfolios. He likes Goldman Sachs (GS) and First Horizon National (FHN) , which appeared on “Mad Money” last week. He would avoid any high-yielding stock however, as they are getting increased competition from risk-free Treasuries.

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

Top Undervalued Stocks To Buy Right Now: Kingtone Wirelessinfo Solution Holding Ltd(KONE)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Top Undervalued Stocks To Buy Right Now: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

  • [By Paul Ausick]

    The subscription service is controlled by Helios & Matheson Analytics Inc. (NASDAQ: HMNY), which owns about 81% of MoviePass stock.

    MoviePass CEO Mitch Lowe commented:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Rich Duprey]

    As movie theater subscription service MoviePass burns through cash at an alarming rate, it is using baling wire and duct tape to cobble together a viable business model. The latest attempt at shoring up a failing strategy is parent Helios and Matheson (NASDAQ:HMNY) acquiring movie database and ticketing site Moviefone.

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Lisa Levin]

    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares dropped 32 percent to $6.87 after the company reported a common stock offering. The size of the offering was not disclosed. The company said that proceeds from the offering and warrants will be used to increase the company’s ownership stake in MoviePass.

Top Undervalued Stocks To Buy Right Now: Vanguard Value ETF (VTV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dynamic Advisor Solutions LLC bought a new stake in Vanguard Value ETF (NYSEARCA:VTV) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,421 shares of the company’s stock, valued at approximately $353,000.

Top Medical Stocks To Watch For 2018

ConforMIS (NASDAQ:CFMS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Wednesday.

According to Zacks, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States. “

Several other research analysts also recently weighed in on the stock. BTIG Research restated a “buy” rating and set a $4.00 price target on shares of ConforMIS in a research report on Wednesday, January 10th. JPMorgan Chase downgraded shares of ConforMIS from a “neutral” rating to an “underweight” rating in a report on Tuesday, January 2nd. Oppenheimer reiterated a “buy” rating on shares of ConforMIS in a report on Thursday, March 22nd. Cowen assumed coverage on shares of ConforMIS in a report on Wednesday, February 21st. They issued an “outperform” rating and a $4.00 price objective for the company. Finally, Canaccord Genuity upgraded shares of ConforMIS from a “hold” rating to a “buy” rating and set a $4.00 price objective for the company in a report on Tuesday, April 10th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. ConforMIS currently has an average rating of “Hold” and a consensus price target of $4.29.

Top Medical Stocks To Watch For 2018: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) dropped about 1.7% Tuesday to post a new 52-week low of $30.44 after closing at $30.95 on Friday. Volume was around 4.1 million about 10% below the daily average of around 4.6 million. The company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.74 after closing Tuesday at $30.76. The 52-week high is $40.20. Volume was about 3.2 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.11 after closing Wednesday at $31.59. The 52-week high is $40.20. Volume was about 9.6 million, more than double the daily average of around 4.2 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.81 after closing Friday at $31.13. The 52-week high is $40.20. Volume was about 3.5 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

Top Medical Stocks To Watch For 2018: Helios and Matheson Analytics Inc(HMNY)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Helios and Matheson Analytics Inc. (Nasdaq: HMNY) is an information technology company that provides its clients predictive analytics. The company uses big data for most of its software and operates within the financial services, insurance, and healthcare industries. HMNY is up 278% YTD after it announced a strategic merger with a GPS application company, called RedZone Maps. RedZone is known for mapping crime in major cities. News of the merger sent HMNY climbing over 1,000% from $1.11 per share to $13.75 per share over the course of a week. The stock has since fallen to $5.23 per share as of Monday intraday.

  • [By Paul Ausick]

    The subscription service is controlled by Helios & Matheson Analytics Inc. (NASDAQ: HMNY), which owns about 81% of MoviePass stock.

    MoviePass CEO Mitch Lowe commented:

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Lisa Levin]

    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares dropped 32 percent to $6.87 after the company reported a common stock offering. The size of the offering was not disclosed. The company said that proceeds from the offering and warrants will be used to increase the company’s ownership stake in MoviePass.

  • [By Peter Graham]

    Small cap analytics stock Helios and Matheson Analytics (NASDAQ: HMNY) is thethird most shorted stock on the NASDAQ with short interest of 54.30% according to Highshortinterest.com. Helios and Matheson Analytics is a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology. The Company owns a majority interest in MoviePass Inc., the nation’s premier movie-theater subscription service.Other holdings include RedZone Map, a safety and navigation app for iOS and Android users, and a community-based ecosystem that features a socially empowered safety map app that enhances mobile GPS navigation using advanced proprietary technology.

Top Medical Stocks To Watch For 2018: EPR Properties(EPR)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    We rate EPR PROPERTIES as a Buy with a ratings score of B. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. 

  • [By Laurie Kulikowski]

    EPR PROPERTIES has improved earnings per share by 11.8% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, EPR PROPERTIES reported lower earnings of $2.78 versus $3.13 in the prior year. This year, the market expects an improvement in earnings ($2.91 versus $2.78).

     

  • [By Laurie Kulikowski]

    EPR’s revenue growth has slightly outpaced the industry average of 6.1%. Since the same quarter one year prior, revenues slightly increased by 9.7%. This growth in revenue appears to have trickled down to the company’s bottom line, improving the earnings per share.

     

Top Medical Stocks To Watch For 2018: China Mobile (Hong Kong) Ltd.(CHL)

Advisors’ Opinion:

  • [By Motif Investing]

    The most heavily weighted names in the motif are China Mobile Ltd. (ADR) (NYSE: CHL), Aibaba Group Holding Ltd (NYSE: BABA), Baidu Inc (NASDAQ: BIDU), India's HDFC Bank (NYSE: HDB) and Russia's Mobile TeleSystems PJSC (NYSE: MBT).

  • [By David Goodboy]

    Rumors are that Apple will use this opportunity to announce the long-awaited deal with China Mobile (NYSE: CHL), which is the world's largest cellphone carrier with more than 700 million active users. Clearly, there are impediments in the way, but the potential for a lower-priced iPhone for this market means strong possibilities remain. This deal would be a major upside catalyst for Apple shares.

  • [By Lisa Levin]

    In trading on Thursday, telecommunications services shares fell 0.12 percent. Meanwhile, top losers in the sector included China Mobile Ltd. (ADR) (NYSE: CHL), down 3 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 1.5 percent.

Top Medical Stocks To Watch For 2018: Emerson Radio Corporation(MSN)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Emerson Radio (MSN) is a marketer of consumer electronic products and various housewares.

    The company has about $1.91 in cash per share, yet sells for less than half that amount. The stock trades at 7.5 times forward earnings. The company is debt free.